The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Cell & Gene Therapy Products – Showcase both Regulatory and CMC Issues via Case Studies and Recent Challenges Toward Solving Regulatory Issues in Japan - Japanese
Date
December 6, 2022
This product is not available for individual purchase, but it is available as part of the following products:
Recently, as the number of approved Regenerative Medical Products (RMPs) in Japan has been rising, companies are expected to face a number of challenges specific to the Cell Therapy and/or Gene Therapy Products…